Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1150831

Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy


Kuzmanović Elabjer, Biljana; Bušić, Mladen; Pleše, Andrej; Bjeloš, Mirjana; Miletić, Daliborka; Vukojević, Nenad
Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy // Ocular Oncology and Pathology, 7 (2021), 3; 224-232 doi:10.1159/000512030 (međunarodna recenzija, članak, ostalo)


CROSBI ID: 1150831 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy

Autori
Kuzmanović Elabjer, Biljana ; Bušić, Mladen ; Pleše, Andrej ; Bjeloš, Mirjana ; Miletić, Daliborka ; Vukojević, Nenad

Izvornik
Ocular Oncology and Pathology (2296-4681) 7 (2021), 3; 224-232

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo

Ključne riječi
Anterior uveal melanoma ; Basal dimension ; Brachytherapy ; Tumor prominence ; Ultrasound biomicroscopy ; Uveal melanoma regression.

Sažetak
Introduction: Ultrasound biomicroscopy (UBM) is the only widely used method for the evaluation of anterior uveal melanoma (AUM). Objective: Documentation of regression of AUM treated with ruthenium-106 (Ru-106) plaque types CCB and CCC using UBM. Methods: This single institution-based retrospective case series involved 10 Caucasian patients with AUM followed after brachytherapy with UBM from January 2014 until February 2019. The largest prominence of the tumor perpendicular to the sclera or the cornea (including scleral/corneal thickness) (D) and the largest basal dimension (B) were measured in millimeters with UBM for all patients prior to the brachytherapy and at 4-month interval follow-up. Tumor regression was calculated as a percentage of decrease in the initial D and B values. Results: The study involved 10 patients with a mean age of 64.4 years (yr) (range 46-80 yr). D ranged from 1.82 to 5.5 mm (median 2.99 mm) and B from 2.32 to 12.38 mm (median 4.18 mm). The apical radiation dose in all patients was 100 Gy. The median follow-up was 42.02 months. Regression for D was 21.11 ± 13.66%, 31.09 ± 14.66%, and 34.92 ± 19.86% at 1st, 2nd, and 3rd year of the follow-up, respectively, while for B it was 21.58 ± 16.05%, 28.98 ± 17.71%, and 32.06 ± 18.96%, respectively. Tumor recurrence was documented in 2/10 patients. Conclusion: The major regression of AUM, treated with Ru-106 plaque types CCB and CCC, was documented in the first 2 years after brachytherapy in our study group. In the following years, only minimal regression was documented that warns of the need for close monitoring and active search for local recurrences.

Izvorni jezik
Engleski



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Kuzmanović Elabjer, Biljana; Bušić, Mladen; Pleše, Andrej; Bjeloš, Mirjana; Miletić, Daliborka; Vukojević, Nenad
Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy // Ocular Oncology and Pathology, 7 (2021), 3; 224-232 doi:10.1159/000512030 (međunarodna recenzija, članak, ostalo)
Kuzmanović Elabjer, B., Bušić, M., Pleše, A., Bjeloš, M., Miletić, D. & Vukojević, N. (2021) Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy. Ocular Oncology and Pathology, 7 (3), 224-232 doi:10.1159/000512030.
@article{article, author = {Kuzmanovi\'{c} Elabjer, Biljana and Bu\v{s}i\'{c}, Mladen and Ple\v{s}e, Andrej and Bjelo\v{s}, Mirjana and Mileti\'{c}, Daliborka and Vukojevi\'{c}, Nenad}, year = {2021}, pages = {224-232}, DOI = {10.1159/000512030}, keywords = {Anterior uveal melanoma, Basal dimension, Brachytherapy, Tumor prominence, Ultrasound biomicroscopy, Uveal melanoma regression.}, journal = {Ocular Oncology and Pathology}, doi = {10.1159/000512030}, volume = {7}, number = {3}, issn = {2296-4681}, title = {Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy}, keyword = {Anterior uveal melanoma, Basal dimension, Brachytherapy, Tumor prominence, Ultrasound biomicroscopy, Uveal melanoma regression.} }
@article{article, author = {Kuzmanovi\'{c} Elabjer, Biljana and Bu\v{s}i\'{c}, Mladen and Ple\v{s}e, Andrej and Bjelo\v{s}, Mirjana and Mileti\'{c}, Daliborka and Vukojevi\'{c}, Nenad}, year = {2021}, pages = {224-232}, DOI = {10.1159/000512030}, keywords = {Anterior uveal melanoma, Basal dimension, Brachytherapy, Tumor prominence, Ultrasound biomicroscopy, Uveal melanoma regression.}, journal = {Ocular Oncology and Pathology}, doi = {10.1159/000512030}, volume = {7}, number = {3}, issn = {2296-4681}, title = {Ultrasound Biomicroscopy Documented Anterior Uveal Melanoma Regression after Ruthenium-106 Plaque Therapy}, keyword = {Anterior uveal melanoma, Basal dimension, Brachytherapy, Tumor prominence, Ultrasound biomicroscopy, Uveal melanoma regression.} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Emerging Sources Citation Index (ESCI)
  • Scopus


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font